.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A breakthrough AMH PCOS blood test has arrived to simplify the diagnosis of Polycystic Ovary Syndrome (PCOS). Redcliffe Labs and Roche Diagnostics India recently launched this diagnostic tool to improve early detection. Consequently, clinicians can now identify Polycystic Ovarian Morphology (PCOM) without relying solely on traditional imaging. This innovation addresses the significant gap in early detection for millions of women across India.
Traditional diagnosis often requires transvaginal ultrasound, which can cause patient discomfort. However, the new blood test offers a minimally invasive alternative that is easier to access. It measures Anti-Müllerian Hormone levels at any point in the menstrual cycle. Therefore, it provides a standardized and cycle-independent approach for healthcare providers. This accuracy ensures that more patients receive timely interventions and proactive hormonal management.
Recent global clinical guidelines from 2023 now recognize AMH as a reliable marker for PCOM in adults. Furthermore, Indian clinical recommendations support this shift towards biochemical markers for easier screening. Studies demonstrate that this method maintains high diagnostic accuracy in diverse populations. Because it reduces the need for specialized imaging, the test improves accessibility in resource-limited settings. Thus, healthcare providers can now manage PCOS cases with greater confidence and speed.
Q1: How does the AMH test compare to traditional ultrasound?
The AMH blood test identifies polycystic morphology by measuring hormone levels instead of counting follicles via imaging. Unlike ultrasound, it is non-invasive and does not depend on the specific phase of the menstrual cycle.
Q2: Who is eligible for this diagnostic tool?
Clinicians recommend this test for adult women showing symptoms of PCOS or those requiring a convenient screening method. It is particularly useful when access to high-quality transvaginal ultrasound is limited or unavailable.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Redcliffe Labs and Roche launch a new AMH-based blood test to simplify PCOS diagnosis and replace ultrasound in India. Learn about its clinical benefits her...
5 months ago
A 2026 meta-analysis evaluates PDE5 inhibitors in advanced ILD with severe gas exchange impairment. While overall mortality was not significantly reduced, a targeted subgroup with pulmonary hypertension showed a 49% risk reduction, underscoring the necessity of precise hemodynamic phenotyping.
Today
A multicentre RCT in China shows that the PAICS AI system significantly boosts sonographer sensitivity in detecting fetal intracranial malformations by 8.7% without compromising specificity, offering promising diagnostic support for prenatal neurosonography.
Today
The Supreme Court questioned FSSAI's phased warning approach, urging single-phase implementation for foods exceeding limits in any nutrient of concern. Backed by ICMR-NIN recommendations, the proposed red hexagonal warnings target added sugar, salt, and fat to combat India's escalating chronic disease epidemic.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A comparative analysis shows that older age, elevated blood glucose, and abdominal adiposity are primary drivers of hypertension. Comprehensive evaluation of cardiometabolic risk profiles enables clinicians to detect overlapping metabolic dysfunctions early and optimize targeted prevention strategies.
Today
